Completed Access to Information Requests

Follow:

  • RSS
  • Cite
About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 203 record(s)

Req # A-2023-025211

With regard to the c. 2003 HDAP Report on New Patented Drug - Angiomax (http://www.pmprbcepmb.gc.ca/view.asp?ccid=583), I am looking for a copy of any supporting research, reports and calculations used to determine dosage regimens. I am specifically interested in how these quantities (in mL) were derived, the benchmark patient weight that was used (in kg) and the timeframe of the dosing.

Organization: Patented Medicine Prices Review Board Canada

18 page(s)
July 2023

Req # A-2023-025599

For FY 2015-2022 (inclusive), how many investigations into prescription pricing on the basis that the pricing exceeded the guidelines resulted in a public hearing? Of those that resulted in a public hearing, in how many was the pricing found to be excessive? Of those that were found to be excessive, how many resulted in orders to reduce the prescription price?

Organization: Patented Medicine Prices Review Board Canada

1 page(s)
July 2023

Req # A-2023-025896

For fiscal years 2015-2022 (inclusive), how many new patented medicines were reported to the board by Bayer, Inc.? From among those reports, how many included claims that a price exceeded the guidelines?

Organization: Patented Medicine Prices Review Board Canada

588 page(s)
July 2023

Req # A-2023-025600

For FY 2015-2022 (inclusive), how many Advance Certificate Rulings were issued by the board?

Organization: Patented Medicine Prices Review Board Canada

0 page(s)
July 2023

Nothing to report this month

Organization: Patented Medicine Prices Review Board Canada

June 2023

Nothing to report this month

Organization: Patented Medicine Prices Review Board Canada

May 2023

Req # A-2022-05126

Provide all emails with keyword “ATIP” from May 1, 2021 to February 23, 2022.

Organization: Patented Medicine Prices Review Board Canada

606 page(s)
April 2023

Req # A-2023-11914

Number of instances in which the ATIP unit used section 20(6) (the public interest override) of the Access to Information Act, as tallied by the documentation retained in accordance with the Manual. No time limit; assess based on period of available documentation (and please indicate this period).

Organization: Patented Medicine Prices Review Board Canada

1 page(s)
April 2023

Req # A-2021-24940

Provide all emails sent to/from Tanya Potashnik from May 1, 2021, to December 19, 2021. Exclude media scans.

Organization: Patented Medicine Prices Review Board Canada

1186 page(s)
April 2023

Req # A-2023-09059

Copies of all submissions or comments received in response to the PMPRB's 2022 Guidelines consultation, including any late consultation submissions received on December 6th or 7th, 2022. This request runs from October 6th to December 7th, 2022. If Health Canada or any other federal government department provided comments outside of the consultation process I would like a copy of those comments as well. This part of the request also runs from October 6th to December 7th, 2022.

Organization: Patented Medicine Prices Review Board Canada

81 page(s)
March 2023
Date modified: